| abstract |
The present invention relates to pyrrolo-pyrazol derivatives, a preparation method therefor and a medical use thereof, and particularly to a novel category of pyrrolo-pyrazol derivatives represented by formula (I), a preparation method therefor and a bio-pharmaceutical use thereof or of pharmaceutical compositions containing the same as therapeutic agents, especially as gastric acid secretion inhibitors and potassium-competitive acid blockers (P-CABs). Substituent groups (Ar and R1) in formula (I) are defined identically as in description. |